Actinium Pharmaceuticals, Inc. (ATNM)
Deferred Revenue
$0.00
Quarterly · Period ending: · USD
ATNM Deferred Revenue
Latest reported$35.00Mperiod ending
Latest reported$35.00Mperiod ending
ATNM FY Deferred Revenue ($0.00 → $35.00M)
Annual deferred revenue
High-resolution chart · PNG
ATNM deferred revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 35,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -4,597,824 | |
| -6,063,243 | |
| 0 | |
| 0 | |
| 25,000 | |
| 214,357 | |
| 81,185 | |
| 31,185 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |